Journal of Clinical Endocrinology & Metabolism, Vol 69, 633-638, Copyright © 1989 by Endocrine Society

ARTICLES

Concurrent aortic and mitral valve echocardiography permits measurement of systolic time intervals as an index of peripheral tissue thyroid functional status

KH Tseng, PG Walfish, JA Persaud and BW Gilbert
Department of Medicine, Mount Sinai Hospital, University of Toronto Medical School, Ontario, Canada.

Systolic time intervals (STI) were measured directly from concurrent aortic and mitral valve echocardiographic tracings in 127 subjects to assess their utility as an index of peripheral tissue thyroid functional status. The subjects were categorized according to clinical symptoms and the results of thyroid function tests into the following 7 study groups: normal subjects (n = 34), overt hyperthyroid subgroup I (n = 12), overt hyperthyroid subgroup II (n = 28), subclinical hyperthyroid (n = 15), subclinical hypothyroid (n = 22), overt hypothyroid subgroup II (n = 6), and overt hypothyroidism subgroup I (n = 10). Compared with normal subjects, overt hyperthyroid subgroup I patients had a significantly shortened mean isovolumetric contraction time (ICT), preejection period (PEP), and PEP/LVET (LVET = left ventricular ejection time; P less than or equal to 0.0005); the overt hypothyroid subgroup I patients also had significantly lengthened mean ICT (P less than or equal to 0.005), PEP, and PEP/LVET (P less than or equal to 0.0005). Compared with normal subjects, overt hyperthyroidism subgroup II patients also had a very significant shortening of ICT (P less than 0.0005) as well as a significantly shortened PEP and PEP/LVET (P less than or equal to 0.005), whereas subclinical hyperthyroid patients (with normal serum free T4 index and total T3, and suppressed TSH by immunoradiometric assay) also had ICT, PEP, and PEP/LVET STI values which were significantly shortened (P less than 0.05) values. Compared to normal subjects, the overt hypothyroid subgroup II patients (who were clinically asymptomatic with reduced serum free T4 index and elevated TSH) had a prolongation of ICT, PEP, and PEP/LVET (P less than or equal to 0.05), whereas the values in subclinical hypothyroid patients were similar to those in normal subjects. From these observations we conclude that in the absence of underlying heart disease, the echocardiographic method used is a rapid, reliable, and sensitive technique for determining STI and provides direct information on peripheral tissue thyroid functional status.

This article has been cited by other articles:

				M. R. A. Martins, F. C. Doin, W. R. Komatsu, T. L. Barros-Neto, V. A. Moises, and J. Abucham Growth Hormone Replacement Improves Thyroxine Biological Effects: Implications for Management of Central Hypothyroidism J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4144 - 4153. [Abstract] [Full Text] [PDF]

				A. Iqbal, H. Schirmer, P. Lunde, Y. Figenschau, K. Rasmussen, and R. Jorde Thyroid Stimulating Hormone and Left Ventricular Function J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3504 - 3510. [Abstract] [Full Text] [PDF]

				G. J. Kahaly and W. H. Dillmann Thyroid Hormone Action in the Heart Endocr. Rev., August 1, 2005; 26(5): 704 - 728. [Abstract] [Full Text] [PDF]

				A. Ripoli, A. Pingitore, B. Favilli, A. Bottoni, S. Turchi, N. F. Osman, D. De Marchi, M. Lombardi, A. L'Abbate, and G. Iervasi Does subclinical hypothyroidism affect cardiac pump performance?: Evidence from a magnetic resonance imaging study J. Am. Coll. Cardiol., February 1, 2005; 45(3): 439 - 445. [Abstract] [Full Text] [PDF]

				B. Biondi, E. A. Palmieri, M. Klain, M. Schlumberger, S. Filetti, and G. Lombardi Subclinical hyperthyroidism: clinical features and treatment options Eur. J. Endocrinol., January 1, 2005; 152(1): 1 - 9. [Abstract] [Full Text] [PDF]

				B. Biondi, E. A. Palmieri, G. Lombardi, and S. Fazio Effects of Subclinical Thyroid Dysfunction on the Heart Ann Intern Med, December 3, 2002; 137(11): 904 - 914. [Abstract] [Full Text] [PDF]

				G. Vitale, M. Galderisi, G. A. Lupoli, A. Celentano, I. Pietropaolo, N. Parenti, O. de Divitiis, and G. Lupoli Left Ventricular Myocardial Impairment in Subclinical Hypothyroidism Assessed by a New Ultrasound Tool: Pulsed Tissue Doppler J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4350 - 4355. [Abstract] [Full Text] [PDF]

				J. W. Chu and L. M. Crapo The Treatment of Subclinical Hypothyroidism Is Seldom Necessary J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4591 - 4599. [Full Text] [PDF]

				F. Monzani, V. Di Bello, N. Caraccio, A. Bertini, D. Giorgi, C. Giusti, and E. Ferrannini Effect of Levothyroxine on Cardiac Function and Structure in Subclinical Hypothyroidism: A Double Blind, Placebo-Controlled Study J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1110 - 1115. [Abstract] [Full Text]

				B. Biondi, S. Fazio, E. A. Palmieri, C. Carella, N. Panza, A. Cittadini, F. Bonè, G. Lombardi, and L. Saccà Left Ventricular Diastolic Dysfunction in Patients with Subclinical Hypothyroidism J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2064 - 2067. [Abstract] [Full Text]

				S. I. Sherman, M. D. Ringel, M. J. Smith, H. A. Kopelen, W. A. Zoghbi, and P. W. Ladenson Augmented Hepatic and Skeletal Thyromimetic Effects of Tiratricol in Comparison with Levothyroxine J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2153 - 2158. [Abstract] [Full Text] [PDF]

				S. K. G. Grebe, R. R. Cooke, H. C. Ford, J. N. Fagerstrom, D. P. Cordwell, N. A. Lever, G. L. Purdie, and C. M. Feek Treatment of Hypothyroidism with Once Weekly Thyroxine J. Clin. Endocrinol. Metab., March 1, 1997; 82(3): 870 - 875. [Abstract] [Full Text] [PDF]